UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): | May 9, 2011 |
UnitedHealth Group Incorporated
__________________________________________
(Exact name of registrant as specified in its charter)
Minnesota | 1-10864 | 41-1321939 |
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
UnitedHealth Group Center, 9900 Bren Road East, Minnetonka, Minnesota | 55343 | |
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
Registrants telephone number, including area code: | 952-936-1300 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
Senior members of UnitedHealth Group Incorporated's (the "Company") management team will be making a presentation at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on May 10, 2011 at 8:00 a.m., Pacific Time. The presentation will focus on a review of the Company's Optum health services business platform and strategy.
The Company will have an audio webcast from the Investors page of its website at www.unitedhealthgroup.com, and will post a copy of the presentation on the Investors page of its website.
The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
UnitedHealth Group Incorporated | ||||
May 9, 2011 | By: |
/s/ Christopher J. Walsh
|
||
|
||||
Name: Christopher J. Walsh | ||||
Title: Executive Vice President and General Counsel |